Generic Name and Formulations:
Azithromycin 1%; oph. soln; contains benzalkonium chloride.
Indications for AZASITE:
Susceptible bacterial conjunctivitis.
Adults and Children:
<1yr: not established. ≥1yr: 1 drop in affected eye(s) twice daily (8–12hrs apart) for 2 days then once daily for the next 5 days.
For topical ophthalmic use only. Discontinue if superinfection or hypersensitivity occurs. Remove contact lenses during therapy. Pregnancy (Cat.B). Nursing mothers.
Eye irritation; blurred vision, burning/pain, contact dermatitis, corneal erosion, dry eye, itching, ocular discharge.
Neurology Advisor Articles
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Patients With Multiple Sclerosis Face Greater Infection Risk
- Fingolimod Compared With Glatiramer Acetate in Head-to-Head MS Study
- Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure